✦ LIBER ✦

Telbivudine and adefovir combination therapy for patients with chronic lamivudine-resistant hepatitis B virus infections

✍ Scribed by Ming-Tsung Lin, Yeh-Pin Chou, Tsung-Hui Hu, Hsien-Chung Yu…

Book ID: 120919711
Publisher: Springer Vienna
Year: 2013
Tongue: English
Weight: 274 KB
Volume: 159
Category: Article
ISSN: 1432-8798
DOI: 10.1007/s00705-013-1786-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Telbivudine in combination with adefovir

Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B

✍ Sang-Hoon Ahn, Young-Oh Kweon, Seung-Woon Paik, Joo-Hyun Sohn, Kwan-Sik Lee, Don 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 272 KB

[502] ADEFOVIR AND LAMIVUDINE COMBINATIO

[502] ADEFOVIR AND LAMIVUDINE COMBINATION THERAPY IS SUPERIOR TO ADEFOVIR MONOTHERAPY FOR LAMIVUDINE-RESISTANT PATIENTS WITH HBeAg-NEGATIVE CHRONIC HEPATITIS B

✍ P. Lampertico; A. Marzano; M. Levrero; T. Santantonio; V. Di Marco; M. Brunette; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Viral kinetics in patients with lamivudi

Viral kinetics in patients with lamivudine-resistant hepatitis B during adefovir–lamivudine combination therapy

✍ Ulrike Mihm; Barbara Christine Gärtner; Dominik Faust; Wolf Peter Hofmann; Chris 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Efficacy of Entecavir and Adefovir Combi

Efficacy of Entecavir and Adefovir Combination Therapy for Patients with Lamivudine- and Entecavir-Resistant Chronic Hepatitis B

✍ Jung Won Jeon; Hyun Phil Shin; Joung Il Lee; Kwang Ro Joo; Jae Myung Cha; Jae Ju 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 199 KB

Dynamics of lamivudine-resistant hepatit

Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy

✍ Samreen Ijaz; Catherine Arnold; Samir Dervisevic; Jana Mechurova; Nick Tatman; R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

## Abstract Adefovir dipivoxil has been used alone or together with lamivudine to suppress lamivudine‐resistant hepatitis B virus (HBV). However, the dynamics of HBV populations under different selection pressures and their impact on treatment outcome are poorly understood. Pyrosequencing® was appl

Lamivudine plus adefovir or entecavir fo

Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir

✍ Nae-Yun Heo; Young-Suk Lim; Han Chu Lee; Young-Hwa Chung; Yung Sang Lee; Dong Ji 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 408 KB